← All stocks

Crinetics Pharmaceuticals, Inc.

CRNX No buying or selling

CIK 0001658247 #989 in the set updated 19 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

15 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

WIERENGA WENDALL

Director

—

116,146

0.1095%

$4.65M

+6.3%

Struthers Richard Scott

President & CEO

—

111,100

0.1047%

$4.44M

−91.3%

Wilson Marc

CFO

—

111,092

0.1047%

$4.44M

0.0%

Knight Jeff E.

Chief Dev. & Operating Officer

—

105,289

0.0993%

$4.21M

+100.2%

Pizzuti Dana

Chief Med and Dev Officer

—

66,837

0.0630%

$2.67M

+120.3%

Vivaldi Coelho Rogerio

Director

—

0.0000%

$0.00

−100.0%

WIERENGA WENDELL

Director

—

0.0000%

$0.00

−100.0%

Deardorf Caren

Director

—

0.0000%

$0.00

−100.0%

Fust Matthew K

Director

—

0.0000%

$0.00

−100.0%

Nichols Weston

Director

—

0.0000%

$0.00

−100.0%

Bedrosian Camille L

Director

—

0.0000%

$0.00

−100.0%

Okey Stephanie

Director

—

0.0000%

$0.00

−100.0%

Betz Stephen F.

Chief Scientific Officer

—

0.0000%

$0.00

−100.0%

Schilke Tobin

Chief Financial & Infra. Ofcr.

—

0.0000%

$0.00

−100.0%

Kalofonos Isabel

Chief Commercial Officer

—

0.0000%

$0.00

−100.0%

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 12

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 1,905,471

History held since 20 Jul 2018